Kymera Therapeutics, Inc.
IRAK degraders and uses thereof
Last updated:
Abstract:
The present invention provides compounds, compositions thereof, and methods of using the same.
Status:
Grant
Type:
Utility
Filling date:
21 Dec 2018
Issue date:
29 Dec 2020